
pmid: 4391189
Seven years ago Schlittler, Druey, and Marxer [207] reported on antihypertensive agents in a previous volume of this series. Since this review appeared, research in the field of antihypertensive drugs has made steady progress. Although spectacular breakthroughs — exemplified by such pioneering feats as the discoveries of reserpine, hydralazine, guanethidine, and chlorothiazide — have become less frequent, a number of important new developments have occurred.
Indoles, Monoamine Oxidase Inhibitors, Hydrolases, Adrenergic beta-Antagonists, Diazoxide, Imidazoles, Blood Pressure, Butyrophenones, Guanidines, Propranolol, Piperazines, Catecholamines, Heterocyclic Compounds, Prostaglandins, Animals, Aromatic Amino Acid Decarboxylase Inhibitors, Humans, Methyldopa, Peptides, Antihypertensive Agents
Indoles, Monoamine Oxidase Inhibitors, Hydrolases, Adrenergic beta-Antagonists, Diazoxide, Imidazoles, Blood Pressure, Butyrophenones, Guanidines, Propranolol, Piperazines, Catecholamines, Heterocyclic Compounds, Prostaglandins, Animals, Aromatic Amino Acid Decarboxylase Inhibitors, Humans, Methyldopa, Peptides, Antihypertensive Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
